Immune checkpoint inhibitor induced colitis: A nationwide population-based study.

Farha, Natalie; Alkhayyat, Motasem; Lindsey, Adrian; Mansoor, Emad; Saleh, Mohannad Abou

Farha, Natalie; Alkhayyat, Motasem; Lindsey, Adrian; Mansoor, Emad; Saleh, Mohannad Abou.

Afiliação

Farha N; Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA.
Alkhayyat M; Department of Gastroenterology, Hepatology & Nutrition, Cleveland Clinic Foundation, Cleveland, OH, USA. Electronic address: alkhaym@ccf.org.
Lindsey A; Division of Gastroenterology and Liver Disease, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Mansoor E; Division of Gastroenterology and Liver Disease, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Saleh MA; Department of Gastroenterology, Hepatology & Nutrition, Cleveland Clinic Foundation, Cleveland, OH, USA.

Clin Res Hepatol Gastroenterol ; 46(1): 101778, 2022 01.

Article em En | MEDLINE | ID: mdl-34332139

Assuntos

Colite; Inibidores de Checkpoint Imunológico; Estudos de Coortes; Colite/induzido quimicamente; Colite/epidemiologia; Colite/patologia; Feminino; Humanos; Inibidores de Checkpoint Imunológico/efeitos adversos; Ipilimumab/efeitos adversos; Nivolumabe/efeitos adversos; Estudos Retrospectivos

Palavras-chave

Colitis; Immune checkpoint inhibitors; Immune-related adverse events

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colite / Inibidores de Checkpoint Imunológico Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google